GPX4 and coronary artery disorder: To verify the clinical applicability of our animal findings, we conducted a study on a cohort of patients undergoing PCI treatment and confirmed the clinical relevance of our research, demonstrating the activation of the STING-GPX4 signaling axis in patients with ischemic heart disease, suggesting that it could potentially have a significant impact on I/R injury.